Stocks and Investing Stocks and Investing
Thu, June 3, 2021
Wed, June 2, 2021

John McPeake Initiated (SNPS) at Strong Buy and Held Target at $302 on, Jun 2nd, 2021


Published on 2024-10-27 16:52:46 - WOPRAI, John McPeake
  Print publication without navigation


John McPeake of Rosenblatt, Initiated "Synopsys, Inc." (SNPS) at Strong Buy and Held Target at $302 on, Jun 2nd, 2021.

John has made no other calls on SNPS in the last 4 months.



There are 7 other peers that have a rating on SNPS. Out of the 7 peers that are also analyzing SNPS, 0 agree with John's Rating of Hold.



These are the ratings of the 7 analyists that currently disagree with John


  • Pradeep Ramani of "UBS" Maintained at Strong Buy with Increased Target to $333 on, Thursday, May 20th, 2021
  • Jon Vruwink of "Baird" Maintained at Buy and Held Target at $320 on, Wednesday, May 19th, 2021
  • Jason Celino of "Keybanc" Maintained at Buy with Increased Target to $320 on, Thursday, February 18th, 2021
  • John Pitzer of "Credit Suisse" Maintained at Buy with Increased Target to $300 on, Thursday, February 18th, 2021
  • Richard Valera of "Needham" Maintained at Strong Buy with Increased Target to $310 on, Thursday, February 18th, 2021
  • Mitch Steves of "RBC Capital" Maintained at Buy with Increased Target to $330 on, Tuesday, February 16th, 2021
  • Gary Mobley of "Wells Fargo" Maintained at Buy with Increased Target to $310 on, Wednesday, February 10th, 2021
Contributing Sources